Over forty batches of the popular cholesterol drug Lipitor have been recalled after concerns that the drug may contain particles of glass.
The manufacturer, Ranbaxy Pharmaceuticals, has recalled its bottles of its 10-, 20- and 40-milligram tablets of atorvastatin calcium, the generic version of Lipitor.
A full list of recalled products can be found here: http://ranbaxyusa.com/images/a.pdf.
Patients are encouraged to contact their pharmacy to determine whether their prescription came from a recalled lot.
Ranbaxy, which is based in India, reached an agreement with the Justice Department in January after being cited for providing false information to the FDA. The conditions of two of its Indian plants were also cited by the FDA in 2006 and 2008. The company has since been banned from manufacturing drugs for the American market at those Indian facilities until they meet U.S standards.
Prescription and over-the-counter medications are intended to improve your quality of life and even sustain life. The FDA is the governmental agency that oversees drug manufacturers and serves as a gatekeeper to introducing new drugs to U.S. patients.
Despite this oversight, many people are injured and even killed by dangerous medical devices and defective drugs each year.
For more information, please contact us.
Source: CNN, "Cholesterol drug recalled over glass concerns," Nov. 25, 2012.